معرفی
Mariana P. Socal is an Associate Professor at the Johns Hopkins Bloomberg School of Public Health in the Department of Health Policy and Management, with a joint appointment at the Carey Business School. Her work bridges medicine, public health, and policy, focusing on pharmaceutical access and affordability in the U.S.
Education:
- PhD in Public Health/Health Systems, Johns Hopkins Bloomberg School of Public Health (2017)
- MPP, Princeton University (2010)
- MSc, Universidade Federal do Rio Grande do Sul (2008)
- MD, Universidade Federal do Rio Grande do Sul (2000)
Her research centers on pharmaceutical policy, including drug pricing, supply chains, biosimilars, insulin, gene therapies, Medicare, and FDA regulation. She investigates how policy interventions can reduce drug costs while preserving access, with a focus on vulnerable populations and systemic reform.
Her recent publications reflect a strong focus on drug shortages, gene therapy access, insulin affordability, and state-level pharmaceutical initiatives like CalRx. Her work frequently appears in top-tier journals such as JAMA, Annals of Internal Medicine, and Health Affairs, highlighting her influence in health policy discourse.
Scientific Awards:
- Member, WHO Technical Advisory Group on Pricing Policies for Medicines (2023–2027)
- Johns Hopkins NEXUS Research Award (2024)
- Excellence in U.S. Public Health Practice Award (2022)
- Multiple Excellence in Teaching Awards (2019–2025)
- Golden Apple Award (2022)
- Gordis Teaching Fellowships (2013, 2015)
Prof. Socal has testified before the U.S. Congress and the FDA on drug pricing and regulation. She collaborates with state governments, including California’s CalRx initiative, and leads the Prescription Drug Supply Chain Data Dashboard (https://supplychain.jhu.edu). She is actively involved in advising and public engagement, though no specific students are listed. She has no indication of part-time status, retirement, or former staff designation.
